Authors of TADS study reply to letter raising concerns.
March
John S
JS
D000293:Adolescent; D018687:Antidepressive Agents, Second-Generation / Q000627:therapeutic use; D015928:Cognitive Behavioral Therapy / Q000379:methods; D003131:Combined Modality Therapy; D003866:Depressive Disorder / Q000628:therapy*; D004311:Double-Blind Method; D005473:Fluoxetine / Q000627:therapeutic use; D006801:Humans; D011613:Psychotherapy / Q000379:methods*; D016032:Randomized Controlled Trials as Topic
D018687:Antidepressive Agents, Second-Generation; D005473:Fluoxetine